1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hypersensitivity Global Clinical Trials Review, H2, 2014

Hypersensitivity Global Clinical Trials Review, H2, 2014

  • October 2014
  • -
  • Global Data
  • -
  • 80 pages

Hypersensitivity Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Hypersensitivity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypersensitivity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypersensitivity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hypersensitivity Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Hypersensitivity 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hypersensitivity to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hypersensitivity to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hypersensitivity 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Hypersensitivity Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Allergy Therapeutics plc 33
Clinical Trial Overview of Allergy Therapeutics plc 33
GlaxoSmithKline plc 35
Clinical Trial Overview of GlaxoSmithKline plc 35
Merck and Co., Inc. 36
Clinical Trial Overview of Merck and Co., Inc. 36
Ono Pharmaceutical Co., Ltd. 37
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 37
Laboratorios LETI S.L. 38
Clinical Trial Overview of Laboratorios LETI S.L. 38
United Pharmaceuticals SA 39
Clinical Trial Overview of United Pharmaceuticals SA 39
Sanofi 40
Clinical Trial Overview of Sanofi 40
Procter and Gamble Srl 41
Clinical Trial Overview of Procter and Gamble Srl 41
Noblewell, Inc 42
Clinical Trial Overview of Noblewell, Inc 42
Allertein Therapeutics, LLC 43
Clinical Trial Overview of Allertein Therapeutics, LLC 43
Clinical Trial Overview of Top Institutes / Government 44
The National Institute of Allergy and Infectious Diseases 44
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 44
The University of North Carolina at Chapel Hill 45
Clinical Trial Overview of The University of North Carolina at Chapel Hill 45
Assistance Publique - Hopitaux de Paris 46
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 46
Maastricht University Medical Center 47
Clinical Trial Overview of Maastricht University Medical Center 47
University Hospital Inselspital, Berne 48
Clinical Trial Overview of University Hospital Inselspital, Berne 48
Imperial College London 49
Clinical Trial Overview of Imperial College London 49
The Children's Hospital of Philadelphia 50
Clinical Trial Overview of The Children's Hospital of Philadelphia 50
Isfahan University of Medical Sciences 51
Clinical Trial Overview of Isfahan University of Medical Sciences 51
Chinese University of Hong Kong 52
Clinical Trial Overview of Chinese University of Hong Kong 52
National Institute of Neurological Disorders and Stroke 53
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 53
Five Key Clinical Profiles 54
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 80

List of Tables

Hypersensitivity Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hypersensitivity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Hypersensitivity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hypersensitivity Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hypersensitivity Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Hypersensitivity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hypersensitivity to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hypersensitivity Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hypersensitivity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hypersensitivity Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Hypersensitivity Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Hypersensitivity Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Hypersensitivity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Hypersensitivity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergy Therapeutics plc, 2014* 33
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 35
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 36
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2014* 37
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios LETI S.L., 2014* 38
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by United Pharmaceuticals SA, 2014* 39
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 40
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Procter and Gamble Srl, 2014* 41
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Noblewell, Inc, 2014* 42
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allertein Therapeutics, LLC, 2014* 43
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 44
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of North Carolina at Chapel Hill, 2014* 45
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 46
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 47
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2014* 48
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 49
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2014* 50
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014* 51
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 52
Hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 53

List of Figures
Hypersensitivity Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hypersensitivity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Hypersensitivity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hypersensitivity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Hypersensitivity Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hypersensitivity to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hypersensitivity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hypersensitivity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hypersensitivity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Hypersensitivity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.